Sviezhentseva, I.O.; Perekhrestenko, T.P.; Bilko, D.I.; Gordienko, A.I.; Diachenko, M.V.; Dyagil, I.S.
(Experimental Oncology, 2015)
Introduction: It is believed that the reason of the leukemic clone cell resistance to treatment with tyrosine kinase inhibitors during chronic myeloid leukemia (CML) is mutations in the genome of an early bone marrow ...